Apellis Pharmaceuticals (APLS) Enterprise Value
Price: $18.20
Market Cap: $2.28B
Avg Volume: 1.96M
Market Cap: $2.28B
Avg Volume: 1.96M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Apellis Pharmaceuticals's latest quarterly financial reports:
- The enterprise value (EV) is 4.01B, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 3.95B, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $31.91, with 123.90M shares outstanding.
- The company has 411.29M in cash and cash equivalents and 469.78M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$4.01B
Market Cap
$3.95B
Total Debt
$469.78M
Cash and Equivalents
$411.29M
Historical Enterprise Value
Apellis Pharmaceuticals Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $4.01B | 10.02% | $31.91 | 123.90M | $3.95B | $411.29M | $469.78M |
| September 30, 2024 | $3.65B | -20.88% | $28.84 | 123.90M | $3.57B | $396.86M | $470.45M |
| June 30, 2024 | $4.61B | -38.09% | $36.29 | 123.90M | $4.50B | $361.43M | $474.51M |
| March 31, 2024 | $7.45B | 6.13% | $59.71 | 122.96M | $7.34B | $327.03M | $430.85M |
| December 31, 2023 | $7.02B | 65.73% | $59.86 | 121.23M | $7.26B | $352.30M | $110.93M |
| September 30, 2023 | $4.23B | -59.16% | $38.04 | 120.29M | $4.58B | $452.41M | $109.58M |
| June 30, 2023 | $10.36B | 51.13% | $91.1 | 119.32M | $10.87B | $616.26M | $110.80M |
| March 31, 2023 | $6.86B | 29.84% | $65.96 | 113.87M | $7.51B | $765.08M | $111.87M |
| December 31, 2022 | $5.28B | -24.36% | $51.71 | 110.63M | $5.72B | $551.80M | $112.71M |
| September 30, 2022 | $6.98B | 57.67% | $68.3 | 109.13M | $7.45B | $584.19M | $113.37M |
| June 30, 2022 | $4.43B | -2.63% | $45.22 | 106.63M | $4.82B | $604.49M | $211.30M |
| March 31, 2022 | $4.55B | 25.64% | $50.81 | 97.84M | $4.97B | $633.46M | $210.42M |
| December 31, 2021 | $3.62B | 31.57% | $47.28 | 85.66M | $4.05B | $640.19M | $210.22M |
| September 30, 2021 | $2.75B | -47.45% | $32.96 | 85.66M | $2.82B | $283.75M | $211.83M |
| June 30, 2021 | $5.24B | 47.76% | $63.2 | 80.65M | $5.10B | $270.76M | $409.63M |
| March 31, 2021 | $3.54B | -14.65% | $42.91 | 79.22M | $3.40B | $265.44M | $409.96M |
| December 31, 2020 | $4.15B | 85.44% | $57.2 | 75.88M | $4.34B | $565.78M | $377.73M |
| September 30, 2020 | $2.24B | -10.88% | $30.17 | 75.63M | $2.28B | $415.56M | $372.88M |
| June 30, 2020 | $2.51B | 46.43% | $32.66 | 75.55M | $2.47B | $317.35M | $362.24M |
| March 31, 2020 | $1.72B | -16.81% | $26.79 | 73.72M | $1.97B | $417.88M | $158.69M |
| December 31, 2019 | $2.06B | 64.20% | $30.62 | 73.72M | $2.26B | $351.99M | $157.03M |
| September 30, 2019 | $1.26B | -5.79% | $24.09 | 63.75M | $1.54B | $433.99M | $154.17M |
| June 30, 2019 | $1.33B | 56.30% | $25.43 | 63.26M | $1.61B | $289.13M | $13.49M |
| March 31, 2019 | $852.96M | 43.83% | $19.48 | 57.90M | $1.13B | $288.25M | $13.37M |
| December 31, 2018 | $593.01M | -24.70% | $13.19 | 56.27M | $742.24M | $176.27M | $27.04M |
| September 30, 2018 | $787.54M | -19.32% | $17.46 | 56.20M | $981.27M | $220.64M | $26.91M |
| June 30, 2018 | $976.14M | -1.10% | $22 | 54.69M | $1.20B | $253.84M | $26.76M |
| March 31, 2018 | $987.01M | 4.67% | $22.11 | 50.35M | $1.11B | $152.93M | $26.62M |
| December 31, 2017 | $943.00M | 78.73% | $21.7 | 50.33M | $1.09B | $175.64M | $26.39M |
| September 30, 2017 | $527.62M | 161.64% | $14.03 | 38.54M | $540.76M | $13.14M | $- |
| June 30, 2017 | $201.66M | -27.65% | $14.03 | 18.09M | $253.84M | $52.19M | $- |
| March 31, 2017 | $278.71M | 21.72% | $14.03 | 18.09M | $253.84M | $-24.86M | $- |
| December 31, 2016 | $228.98M | -9.79% | $14.03 | 18.09M | $253.84M | $24.86M | $- |
| September 30, 2016 | $253.84M | 114.67% | $14.03 | 18.09M | $253.84M | $- | $- |
| June 30, 2016 | $118.25M | -23.34% | $14.03 | 8.43M | $118.25M | $- | $- |
| March 31, 2016 | $154.25M | -29.19% | $14.03 | 8.43M | $118.25M | $-36.00M | $- |
| December 31, 2015 | $217.84M | -10.65% | $14.03 | 18.09M | $253.84M | $36.00M | $- |
| September 30, 2015 | $243.81M | 393.12% | $14.03 | 18.09M | $253.84M | $10.03M | $- |
| June 30, 2015 | $49.44M | 0.00% | $14.03 | 4.58M | $64.31M | $14.87M | $- |
| March 31, 2015 | $49.44M | -79.42% | $14.03 | 4.58M | $64.31M | $14.87M | $- |
| December 31, 2014 | $240.22M | -5.37% | $14.03 | 18.09M | $253.84M | $13.62M | $- |
| September 30, 2014 | $253.84M | 294.76% | $14.03 | 18.09M | $253.84M | $- | $- |
| June 30, 2014 | $64.30M | -6.89% | $14.03 | 4.58M | $64.30M | $- | $- |
| March 31, 2014 | $69.06M | - | $14.03 | 4.58M | $64.30M | $-4.76M | $- |
Related Metrics
Explore detailed financial metrics and analysis for APLS.